(Q51713897)

10 April 2018

title

Hyper-IgM syndrome with systemic tuberculosis. (English)

1 reference

10 April 2018

author name string

Isao Ito

1

1 reference

10 April 2018

Tadashi Ishida

2

1 reference

10 April 2018

Toru Hashimoto

3

1 reference

10 April 2018

Machiko Arita

4

1 reference

10 April 2018

Makoto Osawa

5

1 reference

10 April 2018

Michiaki Mishima

6

1 reference

10 April 2018

Shigeaki Nonoyama

7

1 reference

10 April 2018

publication date

1 January 2002

1 reference

10 April 2018

Scandinavian Journal of Infectious Diseases

published in

1 reference

10 April 2018

volume

34

1 reference

10 April 2018

issue

4

1 reference

10 April 2018

page(s)

305-307

1 reference

10 April 2018

Hypogammaglobulinaemia associated with normal or increased IgM (the hyper IgM syndrome): a case series review

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

Hypogammaglobulinemia with hyper-IgM, severe T-cell defect, and abnormal recirculation of OKT4 lymphocytes in a girl with chronic lymphadenopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

Disruption of CD40-CD40 ligand interactions results in an enhanced susceptibility to Leishmania amazonensis infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

Clinical spectrum of X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

Hyper-IgM immunodeficiency with disseminated cryptococcosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

CD40 ligand is required for protective cell-mediated immunity to Leishmania major

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

Protective role of CD40 in Leishmania major infection at two distinct phases of cell-mediated immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540110080151

10.1080/00365540110080151

21 January 2018

Identifiers

DOI

1 reference

10 April 2018

1 reference

10 April 2018